BC Cancer Agency

LALEAST

NCT03917082

Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer

Status:

Opening soon

26459-200.png

II

Phase

Line of Therapy.png

Adjuvant

Line of Therapy

Disease Stage.png

Early Cancer

Disease Stage

Target.png

Biomarker(s)

HER2-

Investigational

Product

Tamoxifen Citrate

Adjuvant endocrine therapy for two years

Treatment Arms

o standard of care endocrine therapy for two years